DURVAXITY
Live / Applied — Fifth extension granted (statement of use) (as of 20 Nov 2025)
What this means for you
Not registered yet, but its 05 Apr 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97347180
- Mark type
- Stylized text
- Filed
- 05 Apr 2022
- Published for opposition
- 21 Mar 2023
- Attorney of record
- Nancy Sabarra
Goods and services
- Class 001 — Chemicals: Active chemical and biological ingredients for use in the manufacture of pharmaceuticals, namely, for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) encapsulated in lipid nanoparticles for preventing and treating viruses and respiratory disorders; Biochemical preparations for in vivo, ex vivo, on vivo, and in vitro scientific research and medical research; Biochemicals for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; Lipid nanoparticles for scientific, laboratory or medical research use
- Class 005 — Pharmaceuticals: Vaccine adjuvants; Drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticals
- Class 042 — Scientific and technological services: Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines
- Class 044 — Medical, beauty and agricultural services: Medical services; medical information; providing a website featuring medical information
Owner
- Seqirus Inc., Holly Springs, NC, US
- Seqirus Inc., Holly Springs, NC, US
Prosecution history
- 21 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Nov 2025 — SOU EXTENSION 5 GRANTED
- 16 Nov 2025 — SOU EXTENSION 5 FILED
- 17 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 26 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Apr 2025 — SOU EXTENSION 4 GRANTED
- 25 Apr 2025 — SOU EXTENSION 4 FILED
- 25 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Dec 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Dec 2024 — SOU EXTENSION 3 GRANTED
- 12 Nov 2024 — SOU EXTENSION 3 FILED
- 09 Dec 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 09 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 May 2024 — SOU EXTENSION 2 GRANTED